SynthesisSleep & breathing = Schlaf & Atmung2026
Prevalence of coronary atherosclerosis in patients with obstructive sleep apnea syndrome: a systematic review and meta-analysis.
Synthesis in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SIRT1 in Atherosclerosis: Integrative Control of Vascular Metabolism, Inflammation and Aging.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObstructive sleep apnea (OSA) syndrome is a common sleep-related breathing disorder characterized by recurrent episodes of upper airway collapse during sleep. Coronary atherosclerosis, a significant cause of cardiovascular morbidity and mortality worldwide, has been associated with OSA in several studies. However, the precise nature and magnitude of this association remain incompletely defined. This study sought to systematically evaluate the available evidence and quantify the relationship between OSA and coronary atherosclerosis through meta-analysis.
methodA systematic literature review across PubMed, Embase, Cochrane Library, and Web of Science databases was conducted from inception through September 3, 2024. Two investigators performed independent literature screening, data extraction, and quality assessment of included studies. Statistical assessment was performed using Stata 18.
resultsAnalysis of 11 studies encompassing 6587 participants revealed that the overall prevalence of coronary atherosclerosis within the OSA patients was 46% (95% CI: 32%-60%; I2 = 98.5%; P < 0.001). Subgroup analysis demonstrated that coronary atherosclerosis prevalence increased proportionally with OSA severity: 33% (95% CI: 9%-57%; I2 = 99.2%; P < 0.001) in mild OSA, 58% (95% CI: 47%-70%; I2 = 68.4%; P = 0.024) in moderate OSA, and 68% (95% CI: 61%-76%; I2 = 57.2%; P = 0.053) in severe OSA, with an overall prevalence across all severity categories of 50% (95% CI: 34%-66%; P < 0.001).
conclusionThe analysis demonstrates that OSA is associated with an elevated risk of coronary atherosclerosis, with prevalence increasing in parallel with disease severity, it was only demonstrated in observational studies, but not in RCTs.
Indexed as
Identifiers
41686379What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.